Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Ergometrine stability in postpartum haemorrhage kits: Does temperature and light matter?

Donnan F, Senarathna SMDKG, Ware B, Rawlins MDM, Dontham C, Chuang VTG, Batty KT.

Aust N Z J Obstet Gynaecol. 2019 Sep 11. doi: 10.1111/ajo.13046. [Epub ahead of print]

PMID:
31512230
2.

A population pharmacokinetic study of benzathine benzylpenicillin G administration in children and adolescents with rheumatic heart disease: new insights for improved secondary prophylaxis strategies.

Hand RM, Salman S, Newall N, Vine J, Page-Sharp M, Bowen AC, Gray K, Baker A, Kado J, Joseph J, Marsh J, Ramsay J, Sika-Paotonu D, Batty KT, Manning L, Carapetis J.

J Antimicrob Chemother. 2019 Jul 1;74(7):1984-1991. doi: 10.1093/jac/dkz076.

3.

Ertapenem for osteoarticular infections in obese patients: a pharmacokinetic study of plasma and bone concentrations.

Chambers J, Page-Sharp M, Salman S, Dyer J, Davis TME, Batty KT, Manning L.

Eur J Clin Pharmacol. 2019 Apr;75(4):511-517. doi: 10.1007/s00228-018-2597-z. Epub 2018 Dec 4.

PMID:
30511329
4.

Physical compatibility of pentoxifylline and intravenous medications.

Senarathna SMDKG, Strunk T, Petrovski M, Batty KT.

Arch Dis Child. 2019 Mar;104(3):292-295. doi: 10.1136/archdischild-2018-315376. Epub 2018 Nov 24.

PMID:
30472662
5.

Effects of maturation and size on population pharmacokinetics of pentoxifylline and its metabolites in very preterm infants with suspected late-onset sepsis or necrotizing enterocolitis: a pilot study incorporating clinical outcomes.

Salman S, Hibbert J, Page-Sharp M, Manning L, Simmer K, Doherty DA, Patole S, Batty KT, Strunk T.

Br J Clin Pharmacol. 2019 Jan;85(1):147-159. doi: 10.1111/bcp.13775. Epub 2018 Nov 16.

PMID:
30281170
6.

Validation of a Dried Blood Spot Ceftriaxone Assay in Papua New Guinean Children with Severe Bacterial Infections.

Mukap M, Sprod C, Tefuarani N, Laman M, Page-Sharp M, Salman S, Moore BR, Batty KT, Davis TME, Manning L.

Antimicrob Agents Chemother. 2018 Sep 24;62(10). pii: e00940-18. doi: 10.1128/AAC.00940-18. Print 2018 Oct.

7.

Simultaneous determination of pentoxifylline, metabolites M1 (lisofylline), M4 and M5, and caffeine in plasma and dried blood spots for pharmacokinetic studies in preterm infants and neonates.

Page-Sharp M, Strunk T, Salman S, Hibbert J, Patole SK, Manning L, Batty KT.

J Pharm Biomed Anal. 2017 Nov 30;146:302-313. doi: 10.1016/j.jpba.2017.08.030. Epub 2017 Aug 26.

PMID:
28903089
8.

Penicillin Dried Blood Spot Assay for Use in Patients Receiving Intramuscular Benzathine Penicillin G and Other Penicillin Preparations To Prevent Rheumatic Fever.

Page-Sharp M, Coward J, Moore BR, Salman S, Marshall L, Davis TME, Batty KT, Manning L.

Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e00252-17. doi: 10.1128/AAC.00252-17. Print 2017 Aug.

9.

Validation and Application of a Dried Blood Spot Assay for Biofilm-Active Antibiotics Commonly Used for Treatment of Prosthetic Implant Infections.

Knippenberg B, Page-Sharp M, Salman S, Clark B, Dyer J, Batty KT, Davis TM, Manning L.

Antimicrob Agents Chemother. 2016 Jul 22;60(8):4940-55. doi: 10.1128/AAC.00756-16. Print 2016 Aug.

10.

Naphthoquine: An Emerging Candidate for Artemisinin Combination Therapy.

Moore BR, Laman M, Salman S, Batty KT, Page-Sharp M, Hombhanje F, Manning L, Davis TM.

Drugs. 2016 May;76(7):789-804. doi: 10.1007/s40265-016-0572-5. Review.

PMID:
27075024
11.

Safety, tolerability and pharmacokinetic properties of coadministered azithromycin and piperaquine in pregnant Papua New Guinean women.

Moore BR, Benjamin JM, Auyeung SO, Salman S, Yadi G, Griffin S, Page-Sharp M, Batty KT, Siba PM, Mueller I, Rogerson SJ, Davis TM.

Br J Clin Pharmacol. 2016 Jul;82(1):199-212. doi: 10.1111/bcp.12910. Epub 2016 Mar 27.

12.

Use of quantitative pharmacology tools to improve malaria treatments.

Davis TM, Moore BR, Salman S, Page-Sharp M, Batty KT, Manning L.

Expert Rev Clin Pharmacol. 2016;9(2):303-16. doi: 10.1586/17512433.2016.1129273. Epub 2015 Dec 25. Review.

PMID:
26652110
13.

Validation and Application of a Dried Blood Spot Ceftriaxone Assay.

Page-Sharp M, Nunn T, Salman S, Moore BR, Batty KT, Davis TM, Manning L.

Antimicrob Agents Chemother. 2015 Oct 5;60(1):14-23. doi: 10.1128/AAC.01740-15. Print 2016 Jan.

14.

Population pharmacokinetics, tolerability, and safety of dihydroartemisinin-piperaquine and sulfadoxine-pyrimethamine-piperaquine in pregnant and nonpregnant Papua New Guinean women.

Benjamin JM, Moore BR, Salman S, Page-Sharp M, Tawat S, Yadi G, Lorry L, Siba PM, Batty KT, Robinson LJ, Mueller I, Davis TM.

Antimicrob Agents Chemother. 2015 Jul;59(7):4260-71. doi: 10.1128/AAC.00326-15. Epub 2015 May 11.

15.

Pharmacokinetics of piperaquine transfer into the breast milk of Melanesian mothers.

Moore BR, Salman S, Benjamin J, Page-Sharp M, Yadi G, Batty KT, Siba PM, Mueller I, Davis TM.

Antimicrob Agents Chemother. 2015 Jul;59(7):4272-8. doi: 10.1128/AAC.00327-15. Epub 2015 May 11.

16.
17.

Interspecies allometric scaling of antimalarial drugs and potential application to pediatric dosing.

Senarathna SM, Batty KT.

Antimicrob Agents Chemother. 2014 Oct;58(10):6068-78. doi: 10.1128/AAC.02538-14. Epub 2014 Aug 4.

18.

Effect of coadministered fat on the tolerability, safety, and pharmacokinetic properties of dihydroartemisinin-piperaquine in Papua New Guinean children with uncomplicated malaria.

Moore BR, Benjamin JM, Salman S, Griffin S, Ginny E, Page-Sharp M, Robinson LJ, Siba P, Batty KT, Mueller I, Davis TM.

Antimicrob Agents Chemother. 2014 Oct;58(10):5784-94. doi: 10.1128/AAC.03314-14. Epub 2014 Jul 21.

19.

Validation of a chloroquine-induced cell death mechanism for clinical use against malaria.

Ch'ng JH, Lee YQ, Gun SY, Chia WN, Chang ZW, Wong LK, Batty KT, Russell B, Nosten F, Renia L, Tan KS.

Cell Death Dis. 2014 Jun 26;5:e1305. doi: 10.1038/cddis.2014.265.

20.

Predicting the parasite killing effect of artemisinin combination therapy in a murine malaria model.

Patel K, Batty KT, Moore BR, Gibbons PL, Kirkpatrick CM.

J Antimicrob Chemother. 2014 Aug;69(8):2155-63. doi: 10.1093/jac/dku120. Epub 2014 Apr 28.

PMID:
24777899
21.

Modelling the time course of antimalarial parasite killing: a tour of animal and human models, translation and challenges.

Patel K, Simpson JA, Batty KT, Zaloumis S, Kirkpatrick CM.

Br J Clin Pharmacol. 2015 Jan;79(1):97-107. doi: 10.1111/bcp.12288. Review.

22.

Pharmacokinetic properties of single-dose primaquine in Papua New Guinean children: feasibility of abbreviated high-dose regimens for radical cure of vivax malaria.

Moore BR, Salman S, Benjamin J, Page-Sharp M, Robinson LJ, Waita E, Batty KT, Siba P, Mueller I, Davis TM, Betuela I.

Antimicrob Agents Chemother. 2014;58(1):432-9. doi: 10.1128/AAC.01437-13. Epub 2013 Nov 4.

23.

Pharmacokinetics and safety of deferasirox in subjects with chronic kidney disease undergoing haemodialysis.

Maker GL, Siva B, Batty KT, Trengove RD, Ferrari P, Olynyk JK.

Nephrology (Carlton). 2013 Mar;18(3):188-93. doi: 10.1111/nep.12035.

24.

Mechanism-based model of parasite growth and dihydroartemisinin pharmacodynamics in murine malaria.

Patel K, Batty KT, Moore BR, Gibbons PL, Bulitta JB, Kirkpatrick CM.

Antimicrob Agents Chemother. 2013 Jan;57(1):508-16. doi: 10.1128/AAC.01463-12. Epub 2012 Nov 12.

25.

Simultaneous determination of primaquine and carboxyprimaquine in plasma using solid phase extraction and LC-MS assay.

Page-Sharp M, Ilett KF, Betuela I, Davis TM, Batty KT.

J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Aug 1;902:142-6. doi: 10.1016/j.jchromb.2012.06.019. Epub 2012 Jun 25.

PMID:
22771236
26.

Pharmacokinetic comparison of two piperaquine-containing artemisinin combination therapies in Papua New Guinean children with uncomplicated malaria.

Salman S, Page-Sharp M, Batty KT, Kose K, Griffin S, Siba PM, Ilett KF, Mueller I, Davis TM.

Antimicrob Agents Chemother. 2012 Jun;56(6):3288-97. doi: 10.1128/AAC.06232-11. Epub 2012 Apr 2.

27.

Artemisinin-naphthoquine combination therapy for uncomplicated pediatric malaria: a pharmacokinetic study.

Batty KT, Salman S, Moore BR, Benjamin J, Lee ST, Page-Sharp M, Pitus N, Ilett KF, Mueller I, Hombhanje FW, Siba P, Davis TM.

Antimicrob Agents Chemother. 2012 May;56(5):2472-84. doi: 10.1128/AAC.06250-11. Epub 2012 Feb 13.

28.

Synthesis and antimalarial evaluation of novel isocryptolepine derivatives.

Whittell LR, Batty KT, Wong RP, Bolitho EM, Fox SA, Davis TM, Murray PE.

Bioorg Med Chem. 2011 Dec 15;19(24):7519-25. doi: 10.1016/j.bmc.2011.10.037. Epub 2011 Oct 20.

PMID:
22055713
29.

Improving the solubility and bioavailability of dihydroartemisinin by solid dispersions and inclusion complexes.

Ansari MT, Batty KT, Iqbal I, Sunderland VB.

Arch Pharm Res. 2011 May;34(5):757-65. doi: 10.1007/s12272-011-0509-1. Epub 2011 Jun 9.

PMID:
21656361
30.

Pharmacokinetics, pharmacodynamics, and allometric scaling of chloroquine in a murine malaria model.

Moore BR, Page-Sharp M, Stoney JR, Ilett KF, Jago JD, Batty KT.

Antimicrob Agents Chemother. 2011 Aug;55(8):3899-907. doi: 10.1128/AAC.00067-11. Epub 2011 Jun 6.

31.

Investigation of reproductive toxicity of piperaquine in mice.

Batty KT, Moore BR, Stirling V, Ilett KF, Page-Sharp M, Shilkin KB, Mueller I, Rogerson SJ, Karunajeewa HA, Davis TM.

Reprod Toxicol. 2010 Apr;29(2):206-13. doi: 10.1016/j.reprotox.2009.10.013. Epub 2009 Nov 3.

PMID:
19892009
32.

Piperaquine pharmacodynamics and parasite viability in a murine malaria model.

Moore BR, Ilett KF, Page-Sharp M, Jago JD, Batty KT.

Antimicrob Agents Chemother. 2009 Jul;53(7):2707-13. doi: 10.1128/AAC.00056-09. Epub 2009 Apr 20.

33.

Toxicology and pharmacokinetics of piperaquine in mice.

Batty KT, Moore BR, Stirling V, Ilett KF, Page-Sharp M, Shilkin KB, Mueller I, Karunajeewa HA, Davis TM.

Toxicology. 2008 Jul 10;249(1):55-61. doi: 10.1016/j.tox.2008.04.004. Epub 2008 Apr 16.

PMID:
18502018
34.

Pharmacokinetics of dihydroartemisinin in a murine malaria model.

Batty KT, Gibbons PL, Davis TM, Ilett KF.

Am J Trop Med Hyg. 2008 Apr;78(4):641-2.

PMID:
18385362
35.

Plasmodium berghei: parasite clearance after treatment with dihydroartemisinin in an asplenic murine malaria model.

Moore BR, Jago JD, Batty KT.

Exp Parasitol. 2008 Apr;118(4):458-67. Epub 2007 Oct 22.

PMID:
18023429
36.

Pharmacokinetics and pharmacodynamics of piperaquine in a murine malaria model.

Moore BR, Batty KT, Andrzejewski C, Jago JD, Page-Sharp M, Ilett KF.

Antimicrob Agents Chemother. 2008 Jan;52(1):306-11. Epub 2007 Nov 5.

37.

Pharmacokinetics and efficacy of piperaquine and chloroquine in Melanesian children with uncomplicated malaria.

Karunajeewa HA, Ilett KF, Mueller I, Siba P, Law I, Page-Sharp M, Lin E, Lammey J, Batty KT, Davis TM.

Antimicrob Agents Chemother. 2008 Jan;52(1):237-43. Epub 2007 Oct 29.

38.

Pharmacodynamics of doxycycline in a murine malaria model.

Batty KT, Law AS, Stirling V, Moore BR.

Antimicrob Agents Chemother. 2007 Dec;51(12):4477-9. Epub 2007 Sep 17.

39.

Development of a pharmacodynamic model of murine malaria and antimalarial treatment with dihydroartemisinin.

Gibbons PL, Batty KT, Barrett PH, Davis TM, Ilett KF.

Int J Parasitol. 2007 Dec;37(14):1569-76. Epub 2007 May 18.

PMID:
17585920
40.

Retinol supplementation in murine Plasmodium berghei malaria: effects on tissue levels, parasitaemia and lipid peroxidation.

Hamzah J, Batty KT, Davis WA, Mori TA, Ching SY, Croft KD, Davis TM.

Int J Parasitol. 2007 Apr;37(5):525-37. Epub 2006 Nov 27.

PMID:
17157853
41.

Role of P glycoprotein in absorption of novel antimalarial drugs.

Crowe A, Ilett KF, Karunajeewa HA, Batty KT, Davis TM.

Antimicrob Agents Chemother. 2006 Oct;50(10):3504-6. Epub 2006 Aug 17.

42.

In vitro interactions between piperaquine, dihydroartemisinin, and other conventional and novel antimalarial drugs.

Davis TM, Hamzah J, Ilett KF, Karunajeewa HA, Reeder JC, Batty KT, Hackett S, Barrett PH.

Antimicrob Agents Chemother. 2006 Aug;50(8):2883-5.

43.

Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle Diabetes Study.

Clifford RM, Davis WA, Batty KT, Davis TM; Fremantle Diabetes Study.

Diabetes Care. 2005 Apr;28(4):771-6.

PMID:
15793171
44.

Greater use of insulin by southern European compared with Anglo-Celt patients with type 2 diabetes: the Fremantle Diabetes Study.

Clifford RM, Davis WA, Cull CA, Bruce DG, Batty KT, Davis TM.

Eur J Endocrinol. 2004 Nov;151(5):579-86.

PMID:
15538936
46.

Protein binding and alpha : beta anomer ratio of dihydroartemisinin in vivo.

Batty KT, Ilett KF, Davis TM.

Br J Clin Pharmacol. 2004 Apr;57(4):529-33.

47.

Hepatocellular bioactivation and cytotoxicity of the synthetic endoperoxide antimalarial arteflene.

Maggs JL, Bishop LP, Batty KT, Dodd CC, Ilett KF, O'Neill PM, Edwards G, Kevin Park B.

Chem Biol Interact. 2004 Mar 15;147(2):173-84.

PMID:
15013819
48.

Comparison of bioassay and high performance liquid chromatographic assay of artesunate and dihydroartemisinin in plasma.

Kotecka BM, Rieckmann KH, Davis TM, Batty KT, Ilett KF.

Acta Trop. 2003 Aug;87(3):371-5.

PMID:
12875931
49.

Safety and therapeutic efficacy of artesunate suppositories for treatment of malaria in children in Papua New Guinea.

Karunajeewa HA, Kemiki A, Alpers MP, Lorry K, Batty KT, Ilett KF, Davis TM.

Pediatr Infect Dis J. 2003 Mar;22(3):251-6.

PMID:
12634587
50.

Penetration of dihydroartemisinin into cerebrospinal fluid after administration of intravenous artesunate in severe falciparum malaria.

Davis TM, Binh TQ, Ilett KF, Batty KT, Phuöng HL, Chiswell GM, Phuong VD, Agus C.

Antimicrob Agents Chemother. 2003 Jan;47(1):368-70.

Supplemental Content

Loading ...
Support Center